Antigen: Deleted in Liver Cancer 1
Hybridoma Cells Available: No
Antigen Species: Human
Depositor: Clinical Proteomics Technologies for Cancer
Host Species: mouse
Depositors Institution: National Cancer Institute
Positive Tested Species Reactivity: Human
Depositors Notes: This antigen is also known as Rho GTPase-activating protein 7.
Predicted Species Reactivity:
Immunogen: Recombinant Full Length Protein
Alternate Gene Names: Deleted In Liver Cancer 1 Variant 2; ARHGAP7; STARD12; HP; P122-RhoGAP; DLC-1; Deleted In Liver Cancer 1 Protein; Rho-Type GTPase-Activating Protein 7; START Domain-Containing Protein 12; Rho GTPase-Activating Protein 7; StAR-Related Lipid Transfer (START) Domain Containing 12; KIAA1723; StARD12; HP Protein; StAR-Related Lipid Transfer Protein 12
Alternate Antibody Name:
Alternate Antigen Name:
Epitope Mapped: No
Myeloma Strain: P3x63Ag8.653
Epitope Location or Sequence:
Uniprot ID: Q96QB1
Immunogen Sequence: Full length sequence
Antibody Registry ID: AB_2617246
Additional Information: RRID:AB_2617246
Recommended Applications: ELISA, Western Blot
These hybridomas were created by your colleagues. Please acknowledge the hybridoma contributor and the Developmental Studies Hybridoma Bank (DSHB) in the Materials and Methods of your publications. Please email the citation to us.
For your Materials & Methods section:
CPTC-DLC1-1 was deposited to the DSHB by Clinical Proteomics Technologies for Cancer (DSHB Hybridoma Product CPTC-DLC1-1)
Storage and Handling Recommendations
Although many cell products are maintained at 4°C for years without loss of activity, shelf-life at 4°C is highly variable. For immediate use, short term storage at 4°C up to two weeks is recommended. For long term storage, divide the solution into volumes of no less than 20 ul for freezing at -20°C or -80°C. The small volume aliquot should provide sufficient reagent for short term use. Freeze-thaw cycles should be avoided. For concentrate or bioreactor products, an equal volume of glycerol, a cryoprotectant, may be added prior to freezing.
Although the optimal Ig concentration for an application varies for each product and must be optimized for each laboratory, a good starting concentration for immunohistochemistry (IHC), immunofluorescence (IF), and immunocytochemistry (ICC) is 2-5 ug/ml. For western blots, the recommended concentration range is 0.2-0.5 ug/ml.